Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Sales (2020 - 2025)

Vivos Therapeutics' Return on Sales history spans 6 years, with the latest figure at 1.82% for Q4 2025.

  • Quarterly results put Return on Sales at 1.82% for Q4 2025, down 105.0% from a year ago — trailing twelve months through Dec 2025 was 1.22% (down 48.0% YoY), and the annual figure for FY2025 was 1.22%, down 48.0%.
  • Return on Sales for Q4 2025 was 1.82% at Vivos Therapeutics, down from 0.8% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 4.52% in Q4 2022 to a low of 1.82% in Q4 2025.
  • The 5-year median for Return on Sales is 1.04% (2021), against an average of 0.61%.
  • The sharpest move saw Return on Sales skyrocketed 483bps in 2021, then plummeted -583bps in 2023.
  • Year by year, Return on Sales stood at 2.94% in 2021, then skyrocketed by 54bps to 4.52% in 2022, then crashed by -129bps to 1.31% in 2023, then surged by 42bps to 0.76% in 2024, then tumbled by -138bps to 1.82% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.82%, 0.8%, and 1.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.